164 related articles for article (PubMed ID: 18300097)
1. The behavior of different carrageenans in pelletization by extrusion/spheronization.
Thommes M; Kleinebudde P
Pharm Dev Technol; 2008; 13(1):27-35. PubMed ID: 18300097
[TBL] [Abstract][Full Text] [Related]
2. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
[TBL] [Abstract][Full Text] [Related]
3. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
Verheyen P; Steffens KJ; Kleinebudde P
Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
[TBL] [Abstract][Full Text] [Related]
4. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
[TBL] [Abstract][Full Text] [Related]
5. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
[TBL] [Abstract][Full Text] [Related]
6. New insights into the pelletization mechanism by extrusion/spheronization.
Koester M; Thommes M
AAPS PharmSciTech; 2010 Dec; 11(4):1549-51. PubMed ID: 21042960
[TBL] [Abstract][Full Text] [Related]
7. Influence of MCC II fraction and storage conditions on pellet properties.
Krueger C; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
[TBL] [Abstract][Full Text] [Related]
8. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
Thommes M; Kleinebudde P
AAPS PharmSciTech; 2007 Nov; 8(4):E95. PubMed ID: 18181555
[TBL] [Abstract][Full Text] [Related]
9. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures.
Kleinebudde P; Schröder M; Schultz P; Müller BW; Waaler T; Nymo L
Pharm Dev Technol; 1999 Aug; 4(3):397-404. PubMed ID: 10434285
[TBL] [Abstract][Full Text] [Related]
10. Systematic evaluations regarding interparticular mass transfer in spheronization.
Koester M; Willemsen E; Krueger C; Thommes M
Int J Pharm; 2012 Jul; 431(1-2):84-9. PubMed ID: 22546294
[TBL] [Abstract][Full Text] [Related]
11. Effect of drying on extruded pellets based on kappa-carrageenan.
Thommes M; Blaschek W; Kleinebudde P
Eur J Pharm Sci; 2007 Jun; 31(2):112-8. PubMed ID: 17448646
[TBL] [Abstract][Full Text] [Related]
12. Insights into the functionality of pelletization aid in pelletization by extrusion-spheronization.
Sarkar S; Heng PW; Liew CV
Pharm Dev Technol; 2013 Feb; 18(1):61-72. PubMed ID: 21981607
[TBL] [Abstract][Full Text] [Related]
13. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization.
Koo OM; Heng PW
Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1383-7. PubMed ID: 11724226
[TBL] [Abstract][Full Text] [Related]
14. Multiple batch manufacturing of theophylline pellets using the wet-extrusion/spheronization process with κ-carrageenan as pelletisation aid.
Krueger C; Thommes M
Pharm Dev Technol; 2013 Feb; 18(1):225-35. PubMed ID: 22780876
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of microcrystalline cellulose II (MCCII) as an alternative extrusion-spheronization aid.
Rojas J; Kumar V
Pharmazie; 2012 Jul; 67(7):595-7. PubMed ID: 22888514
[TBL] [Abstract][Full Text] [Related]
16. Influence of the surface tension of wet massing liquid on the functionality of microcrystalline cellulose as pelletization aid.
Elsergany RN; Lenhart V; Kleinebudde P
Eur J Pharm Biopharm; 2020 Aug; 153():285-296. PubMed ID: 32599270
[TBL] [Abstract][Full Text] [Related]
17. Preliminary assessment of carrageenan as excipient for extrusion/spheronisation.
Bornhöft M; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2005 Jan; 59(1):127-31. PubMed ID: 15567309
[TBL] [Abstract][Full Text] [Related]
18. Influence of starting material particle size on pellet surface roughness.
Sarkar S; Ang BH; Liew CV
AAPS PharmSciTech; 2014 Feb; 15(1):131-9. PubMed ID: 24198222
[TBL] [Abstract][Full Text] [Related]
19. Preparing of pellets by extrusion/spheronization using different types of equipment and process conditions.
Bölcskei É; Regdon G; Sovány T; Ghanam D; Knop K; Kleinebudde P; Pintye-Hódi K
Drug Dev Ind Pharm; 2014 Jun; 40(6):762-4. PubMed ID: 23596971
[TBL] [Abstract][Full Text] [Related]
20. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
